Doctor Lieke Feijen

Lieke Feijen is senior scientist with the DCCSS LATER group Kremer, since 2015. She finished her PhD in 2015, the topic of her thesis was cardiotoxicity after childhood cancer treatment. She is a co-PI at a large Dutch Heart Association grant (2016), a co-PI at a Pilot study funded by KiKa (2020) and was the work package coordinator in a large pan-European project about late effects, specifically cardiotoxicity.